Interleukin-35 as a key immunoregulatory mediator in steroid-hyporesponsive severe asthma
Severe asthma remains a major unmet clinical challenge, largely due to corticosteroid hyporesponsiveness in a subset of patients. Despite high-dose inhaled or systemic corticosteroids and targeted biologics, chronic airway inflammation often persists, …